$SNOW

Snowflake stock skyrockets as enterprise AI adoption powers 'flywheel' across cloud platform business

Snowflake (SNOW) stock rose 20% in pre-market trading after reporting a 35% revenue increase to $1.55 billion in Q2. CEO Sridhar Ramaswamy attributed growth to AI adoption, noting a 'flywheel' effect. Adjusted EPS was $0.62. AI tools like Cortex and CoWork drove half of the growth acceleration. YTD, SNOW stock is up 40%.

Original reporting
Published Sep 3, 2026, 1:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 3, 2026, 2:25 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Snowflake stock skyrockets as enterprise AI adoption powers 'flywheel' across cloud platform business — source image
Decision brief

The 30-second read

$SNOWBullishHigh
01

Why it matters

The earnings beat reinforces the narrative that AI adoption is translating into higher data platform spend.

02

Market read

Snowflake's strong Q2 results and AI‑centric growth story provide a fresh catalyst for tech‑heavy portfolios.

03

What to watch

Potential margin pressure from rapid scaling and competition from larger cloud providers.

Relevance 9/10Novelty 9/10Timing: pre‑market today

Background

Snowflake's earnings beat follows a broader AI hype cycle boosting cloud data platforms.

Company-level read

Ticker impact

$SNOWBullishHigh confidence
Context

Snowflake reported Q2 FY2027 revenue up 35% to $1.55B and adjusted EPS $0.62, driving a 20% pre‑market surge.

Expected impact

Expect continued upside pressure; target price may rise 8‑12% over the next week.

Evidence & confidence

Revenue beat, high AI adoption, and a sizable pre‑market jump indicate fresh buying interest and momentum.

Market effects

AI‑driven data‑cloud services sector may see broader rally as Snowflake validates demand.

U.S. tech equities likely benefit from the positive earnings surprise.

Global cloud and AI vendors could see increased investor attention.

Counterpoint

If AI spend slows, Snowflake's growth could be unsustainable, prompting a pullback.

Key entities

  • Snowflake

    Cloud‑based data‑warehousing provider.

  • Sridhar Ramaswamy

    CEO of Snowflake.

Related articles

$SNOWHighAI 8/10

Snowflake stock skyrockets on AI-driven Q2 revenue jump

Snowflake (SNOW) stock rose 20% premarket after reporting Q2 revenue of $1.55B, up 35%. CEO Ramaswamy attributed growth to AI-driven customer usage. Adjusted EPS was $0.62. AI products contributed significantly to growth, with tools like Cortex and CoWork seeing rapid adoption. Year-to-date, SNOW stock is up over 40%.

$SNOWMedAI 8/10

Snowflake’s AI Efforts Accelerate, but Can Margins Withstand the Pressure?

Snowflake (SNOW) reported Q2 revenue of $1.55B, up 35% YoY, beating EPS estimates by 39%. The company raised FY27 operating margin guidance to 14.5% but cut product gross margin to 74% due to AI product pressures. AI adoption metrics showed strong growth, with Cortex AI and CoCo reaching 9,100 accounts each. Shares initially fell 4% pre-earnings but surged 22.8% post-results.

$DDOGHighAI 8/10

Datadog Stock Rises 5% on Snowflake's 37% Growth

Datadog (DDOG) rose 5.02% premarket, following Snowflake's (SNOW) 37% revenue growth and raised guidance. Snowflake shares surged 23.33%. Datadog has faced pressure since its earnings report, despite beating estimates and raising its outlook, due to a large customer's reduced usage.

$AVGOMed

Global stocks, bonds recover as rising Gulf tensions prop up oil

Global stocks and bonds recovered, with the STOXX 600 up 0.2% and U.S. futures rising 0.1%. Oil prices increased to $95/barrel due to U.S.-Iran tensions. Broadcom shares fell 2% on weak forecasts, while Snowflake shares surged 20% on strong revenue guidance. Investors await U.S. payroll data and Fed comments. The yen strengthened, and bond yields fell.

$SNOWMed

Stocks making the biggest moves premarket: Snowflake, Moderna, Broadcom & more

Snowflake shares surged 24% after Q2 results beat estimates, with revenue of $1.55B and EPS of $0.62. Broadcom fell 2.5% on lower Q4 revenue forecasts. Campbell's dropped 7% on weak fiscal 2027 guidance. Ultragenyx plunged 46% after a failed drug trial. Petco rose 9% on strong Q2 margins. Moderna declined 2% after a downgrade. Argan gained 7.5% on better-than-expected earnings. Five Below rose 4.5% on strong Q2 results. Victoria's Secret fell 18% on missed revenue estimates. Netskope rose 12% on